EBAY
56
2
CF
36
-2
APD
52
2
AAL
48
-2
BAX
41
3
D
46
3
CNX
38
-3
AN
50
-2
CAG
36
2
ADT
50
2
CPB
39
2
DOV
71
10
CCL
82
-4
BWA
55
2
ADI
73
-3
CVS
43
2
C
81
-4
DG
72
4
CAT
69
11
AIZ
76
-2
EBAY
56
2
CF
36
-2
APD
52
2
AAL
48
-2
BAX
41
3
D
46
3
CNX
38
-3
AN
50
-2
CAG
36
2
ADT
50
2
CPB
39
2
DOV
71
10
CCL
82
-4
BWA
55
2
ADI
73
-3
CVS
43
2
C
81
-4
DG
72
4
CAT
69
11
AIZ
76
-2
Financhill
Back

Enliven Therapeutics, Inc. 10K Form

Sell
21

ELVN
Enliven Therapeutics, Inc.

Last Price:
$16.27
Seasonality Move:
-8.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ELVN News And Ratings

See the #1 stock for the next 7 days that we like better than ELVN

ELVN Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-13.3M
Price / Cash Flow: 0
Annual Sales: $8.03
Price / Book: 2.03

Profitability

EPS (TTM): -1.84590
Net Income (TTM): $-97.2M
Gross Margin: $-317K
Return on Equity: -26.26%
Return on Assets: -25.2%

Enliven Therapeutics, Inc. Earnings Forecast

Key Enliven Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 8 years have been positive in 3 years.

Enliven Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ELVN
Website: enliventherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 32.95
Quick Ratio: 32.6

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ELVN Technical Analysis vs Fundamental Analysis

Sell
21
Enliven Therapeutics, Inc. (ELVN) is a Sell

Is Enliven Therapeutics, Inc. a Buy or a Sell?